Innovation and the Bioethics Committee – When Is Approval Required?
Innovators aiming to test their technology in a hospital environment should be aware that most solutions involving patient interaction—whether direct or indirect (e.g., tools supporting physicians)—will require approval from a bioethics committee. While this is obvious for uncertified technologies due to patient risk, it’s crucial to understand that even certified technologies may require approval if they go beyond standard care practices.
Example? If a certified diagnostic device is to be tested for a condition outside its approved scope, bioethics committee approval is mandatory before hospital testing begins. Some hospitals have internal bioethics committees, which may streamline the process, but hospital consent alone does not equate to bioethics approval.
Bioethics Committee Approval
A hospital’s bioethics committee is responsible for overseeing and evaluating research activities. Its mission is to protect the rights, dignity, and safety of patients involved in studies. The committee assesses potential risks and benefits of new technologies, influencing the decision to grant approval. Approval is essential, as the committee comprises experts from various fields who evaluate the project from multiple perspectives, ensuring patient safety.
Applications for approval vary depending on the committee and project type. Typically, they include:
- Basic information about the research entity
- Title and rationale of the experiment
- Details of the responsible investigator
- Insurance coverage for participants
- Expected therapeutic and cognitive benefits
- Risk assessment
This allows for both substantive and ethical evaluation. While physicians are familiar with such documentation, for first-time innovators, it may be a challenge.
Informed Consent – A Key Element
A critical component of the application and the entire study is the informed consent form. It must include:
- Voluntary agreement to participate after reviewing study information
- Confirmation of the right to ask questions and receive answers
- Information about the right to withdraw at any time
Patient consent is a cornerstone of ethical research, ensuring respect, safety, and informed participation. Each patient must receive age-appropriate information.
Example? If testing a pedometer with 6-year-olds, materials should be adapted—e.g., pictorial forms. While legal consent is signed by guardians, the child must still understand their right to withdraw.
Defining the Type of Study
Innovators must correctly identify the type of study and submit the appropriate application. It may be:
- Clinical trial
- Medical experiment, including:
- Therapeutic experiment – new or partially tested methods to save health/life
- Research experiment – aimed at expanding medical knowledge
- Observational study – requires approval if it involves patient interaction
- Retrospective study – analysis of existing medical data. Often classified as non-interventional observational studies. If personal data is involved → bioethics opinion is required, especially for sensitive data.
Time and Expectations for Testing
Collaboration with hospitals, especially public ones, requires patience and understanding of internal processes. Unlike commercial environments, decisions are often collegial, procedural, and risk-assessed. Documentation preparation may take days or weeks. Public institutions may be subject to public procurement law, so it’s worth checking its applicability to pilots or innovation purchases. Ethics and safety are paramount – bypassing the bioethics committee or borderline legal interpretations are unacceptable. Hospitals prioritize patient welfare over innovation.
Summary
While obtaining bioethics committee approval may seem complex and time-consuming, with well-prepared documentation and experienced support, it becomes a natural step in hospital innovation implementation. Handled properly, it not only removes barriers but builds credibility and trust among medical staff and patients.
Useful Legal Sources and Guidelines Regulating Medical Research in Poland
- Act on the Professions of Physician and Dentist (Dz.U. 1996 nr 28 poz. 152) – regulates medical experiments
- Pharmaceutical Law and EU Regulation 536/2014 – rules for clinical trials of medicinal products
- Act on Medical Devices (Dz.U. 2022 poz. 974) – regulates clinical trials of medical devices
- Act on Patient Rights and the Patient Ombudsman – governs patient consent and access to medical documentation
- GDPR – crucial for retrospective and observational studies involving patient data
Author: Ewelina Tomaszczyk
Project Manager with experience in corporate finance, startup development, and innovative product creation. She specializes in market analysis, financing strategies, and business positioning, combining her expertise in economics with a passion for new technologies. She advises companies on product development and target audience identification.